-
FDA Approves Topical Cream for Inflammatory Rosacea
The FDA approved benzoyl peroxide 5% cream (Epsolay) for adults with inflammatory lesions of rosacea. The medication uses…
-
Nonstimulant Approved for Adult ADHD
The FDA approved the use of viloxazine (Qelbree) extended-release capsules for adults 18 years of age and older…
-
FDA Warns of Risks Associated With Noninvasive Prenatal Screening Tests
The FDA is warning the public of the risk of false results, inappropriate use, and inappropriate interpretation of…
-
FDA Approves First Sublingual Medication for Agitation in Serious Mental Illness
The FDA approved dexmedetomidine (Igalmi) sublingual film for the acute treatment of agitation associated with schizophrenia or bipolar…
-
FDA Approves New Indication for IL-23 Inhibitor for Adults With Active Psoriatic Arthritis
Risankizumab-rzaa (Skyrizi) is now approved for the treatment of adults with active psoriatic arthritis. It is the only…
-
FDA Approves Treatment for Wider Range of Patients With Heart Failure
The FDA approved empagliflozin (Jardiance) to reduce the risk of cardiovascular death and hospitalization for heart failure in…
-
First Generic of Cyclosporine Ophthalmic Emulsion Eye Drops (Restasis) Approved for Dry Eye
The FDA approved the first generic version of cyclosporine ophthalmic emulsion 0.05% single-use vials (Restasis) to increase tear…
-
Rivaroxaban (Xarelto) Approved for Pediatric Indication to Help Prevent, Treat Clots
The FDA approved two new pediatric indications for rivaroxaban (Xarelto), a factor Xa anticoagulant with multiple indications in…
-
New Medication Spray Approved for Seasonal Allergic Rhinitis
The FDA approved olopatadine hydrochloride/mometasone furoate (Ryaltris) nasal spray, a combination histamine-1(H1)-receptor inhibitor/corticosteroid, for the treatment of symptoms…
-
New Biologic Drug Approved for Moderate to Severe Atopic Dermatitis
The FDA approved tralokinumab-ldrm (Adbry), a biologic for the treatment of moderate-to-severe atopic dermatitis in adults 18 years…
-
FDA Approves New Drug for Insomnia in Adults
The FDA has approved daridorexant (Quviviq) 25 mg and 50 mg for the treatment of adult patients with…
-
Vaginal Gel Approved for Bacterial Vaginosis
The FDA approved clindamycin phosphate vaginal gel, 2% (Xaciato), for the treatment of bacterial vaginosis in females 12…
Trending
-
FDA Approved Semaglutide Injection to Reduce Risk of Serious Heart Problems in Overweight Adults
-
The Role of Pharmacogenomics in Precision Mental Healthcare
-
Using Technology to Combat Drug-Drug Interactions
-
Building a Strong Professional Nursing Network as a New Nurse Practitioner
-
FDA Releases Updated Women’s Health Research Roadmap
-
Counterfeit Prescriptions from Online Pharmacies Are Posing a Health Risk
-
Compounding Group Sues FDA for Removing Weight-Loss Medications from Short-Supply List
-
New Approach Announced for Processing Complaints to the FDA
-
When, Why, and How to Prescribe During Cold and Flu Season
-
Tips for Landing Your First Nurse Practitioner Job
-
How Teamwork Can Help Prevent Malpractice Incidents for Nurse Practitioners
-
Sharpen Your Sherlock Skills: Mastering the Art of the Differential Diagnosis
Join our email list
Get new course alerts, newsletters and more delivered directly to your inbox
By providing my personal information, including phone number, I consent to (1) receive email messages with information and offers, autodialed calls, texts, and prerecorded messages from FHEA, including current and possible future services, customer service and billing; and (2) FHEA’s Privacy Policy and Terms and Conditions. I understand that my consent is not required to purchase, and that cancellation of purchase does not automatically revoke this consent.